Development and comparative evaluation of two immunoassay platforms for bioanalysis of crizotinib: A potent drug used for the treatment of non-small cell lung cancer.
Sign Up to like & getrecommendations! Published in 2019 at "Talanta"
DOI: 10.1016/j.talanta.2019.04.013
Abstract: This study describes, for the first time, the development of two platforms of competitive fluorescent immunoassays for bioanalysis of crizotinib (CZT), a potent drug used for the treatment of non-small cell lung cancer (NSCLC). These… read more here.
Keywords: czt; kinexa; drug; drug used ... See more keywords
1946. Heterogeneous Hospitalization Outcomes of People Who Use Drugs: The Type of Drug(s) Used Matters
Sign Up to like & getrecommendations! Published in 2018 at "Open Forum Infectious Diseases"
DOI: 10.1093/ofid/ofy210.1602
Abstract: Abstract Background US hospitals are experiencing an increase in admissions for persons who use drugs (PWUD). We examined predictors of two outcomes—leaving AMA and 30-day readmission—among PWUD. Methods We limited the 2013 National Readmissions Database… read more here.
Keywords: drug used; use drugs; ref; ref ref ... See more keywords